Obang, Ruthchiel B.

HRN: 28-60-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2026
AMPICILLIN 1GM (VIAL)
02/21/2026
02/22/2026
IVTT
2g
Q6h
THICKLY MSAF
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpirical De-escalation    Type of Infection:  Reproductive Tract    Compliance to guidelines: